Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kornmueller, K; Amri, EZ; Scheideler, M; Prassl, R.
Delivery of miRNAs to the adipose organ for metabolic health.
Adv Drug Deliv Rev. 2022; 181:114110
Doi: 10.1016/j.addr.2021.114110
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Kornmüller Karin
- Prassl Ruth
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Despite the increasing prevalence of obesity and diabetes, there is no efficient treatment to combat these epidemics. The adipose organ is the main site for energy storage and plays a pivotal role in whole body lipid metabolism and energy homeostasis, including remodeling and dysfunction of adipocytes and adipose tissues in obesity and diabetes. Thus, restoring and balancing metabolic functions in the adipose organ is in demand. MiRNAs represent a novel class of drugs and drug targets, as they are heavily involved in the regulation of many cellular and metabolic processes and diseases, likewise in adipocytes. In this review, we summarize key regulatory activities of miRNAs in the adipose organ, discuss various miRNA replacement and inhibition strategies, promising delivery systems for miRNAs and reflect the future of novel miRNA-based therapeutics to target adipose tissues with the ultimate goal to combat metabolic disorders.
- Find related publications in this database (using NLM MeSH Indexing)
- Adipocytes - metabolism
- Adipose Tissue - drug effects, metabolism
- Diabetes Mellitus, Type 2 - physiopathology
- Drug Delivery Systems - methods
- Humans - administration & dosage
- Insulin Resistance - physiology
- Lipid Metabolism - physiology
- Metabolic Diseases - physiopathology
- MicroRNAs - administration & dosage, pharmacology
- Find related publications in this database (Keywords)
- Obesity
- Adipose tissues
- miRNA therapeutics
- Delivery systems